I will add a brief note of agreement with the amendment, for the obvious reason that this country’s pharmaceutical industry is our most important and must be involved in drug trials. I have seen this myself, having been involved with various clinical trials in the past. These have been of benefit to British patients and, subsequently, to our economy.
European Union (Withdrawal) Bill
Proceeding contribution from
Lord Winston
(Labour)
in the House of Lords on Monday, 12 March 2018.
It occurred during Committee of the Whole House (HL)
and
Debate on bills on European Union (Withdrawal) Bill.
About this proceeding contribution
Reference
789 c1334 Session
2017-19Chamber / Committee
House of Lords chamberLibrarians' tools
Timestamp
2018-03-13 12:43:48 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000101
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000101
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000101